Platelet activating factor

Platelet activating factor is a lipid of Glycerophospholipids (GP) class. Platelet activating factor is associated with abnormalities such as Atherosclerosis, Acute cholecystitis without calculus, Cholecystitis, Colitis and Cholecystitis, Acute. The involved functions are known as Cell Survival, Metabolic Inhibition, lipid oxidation, Apoptosis and Oxidation. Platelet activating factor often locates in soluble, Cellular Membrane, Smooth muscle (tissue), Intima and Tissue specimen. The associated genes with Platelet activating factor are apolipoprotein A-I Milano, Homologous Gene, TSPO gene, HBEGF gene and SLC33A1 gene. The related lipids are Hydroxycholesterols, Liposomes, 25-hydroxycholesterol, Lysophosphatidylcholines and Lipopolysaccharides. The related experimental models are Knock-out, Mouse Model and Transgenic Model.

Cross Reference

Introduction

To understand associated biological information of Platelet activating factor, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with Platelet activating factor?

Platelet activating factor is suspected in Ischemia, Pleurisy, Atherosclerosis, Inflammatory disorder, Retinal Diseases, Diabetes and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with Platelet activating factor

MeSH term MeSH ID Detail
Hemolysis D006461 131 associated lipids
Uremia D014511 33 associated lipids
Colitis, Ulcerative D003093 24 associated lipids
Stomach Ulcer D013276 75 associated lipids
Kidney Failure, Chronic D007676 51 associated lipids
Diabetes Mellitus D003920 90 associated lipids
Hypoxia D000860 23 associated lipids
Arrhythmias, Cardiac D001145 42 associated lipids
Hypercalcemia D006934 13 associated lipids
Neovascularization, Pathologic D009389 39 associated lipids
Per page 10 20 50 100 | Total 288

PubChem Associated disorders and diseases

What pathways are associated with Platelet activating factor

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with Platelet activating factor?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with Platelet activating factor?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with Platelet activating factor?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with Platelet activating factor?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with Platelet activating factor?

Knock-out

Knock-out are used in the study 'A cardioprotective role for platelet-activating factor through NOS-dependent S-nitrosylation.' (Leary PJ et al., 2008).

Mouse Model

Mouse Model are used in the study 'A regulatory role of LPCAT1 in the synthesis of inflammatory lipids, PAF and LPC, in the retina of diabetic mice.' (Cheng L et al., 2009).

Transgenic Model

Transgenic Model are used in the study 'Heterogeneity in the sn-1 carbon chain of platelet-activating factor glycerophospholipids determines pro- or anti-apoptotic signaling in primary neurons.' (Ryan SD et al., 2008).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with Platelet activating factor

Download all related citations
Per page 10 20 50 100 | Total 8526
Authors Title Published Journal PubMed Link
Zang BX et al. [Inhibitory effect of kaempferol against binding of platelet activating factor to its receptor]. 2004 Zhongguo Zhong Yao Za Zhi pmid:15506296
Bankers-Fulbright JL et al. Platelet-activating factor stimulates cytoplasmic alkalinization and granule acidification in human eosinophils. 2004 J. Cell. Sci. pmid:15507482
Hertelendy F and Zakár T Prostaglandins and the myometrium and cervix. 2004 Prostaglandins Leukot. Essent. Fatty Acids pmid:14683694
Diez-Fraile A et al. Effect of proinflammatory mediators and glucocorticoids on L-selectin expression in peripheral blood neutrophils from dairy cows in various stages of lactation. 2004 Am. J. Vet. Res. pmid:15524330
Mangan NE et al. Helminth infection protects mice from anaphylaxis via IL-10-producing B cells. 2004 J. Immunol. pmid:15528374
Jung TT et al. Effect of inhibitors of leukotriene and/or platelet activating factor on killed H. influenzae induced experimental otitis media with effusion. 2004 Int. J. Pediatr. Otorhinolaryngol. pmid:14687688
Barbanoj MJ et al. Central and peripheral evaluation of rupatadine, a new antihistamine/platelet-activating factor antagonist, at different doses in healthy volunteers. 2004 Neuropsychobiology pmid:15539863
Fujii S et al. Chromogenic assay for the activity of sphingomyelinase from Bacillus cereus and its application to the enzymatic hydrolysis of lysophospholipids. 2004 Biol. Pharm. Bull. pmid:15516713
Göggel R et al. PAF-mediated pulmonary edema: a new role for acid sphingomyelinase and ceramide. 2004 Nat. Med. pmid:14704790
Suenaga A and Ueki H Effect of orthovanadate on platelet aggregation induced by platelet-activating factor. 2004 Biol. Pharm. Bull. pmid:15516737
Tsutsumi T et al. Phorbol myristate acetate stimulates degradation of a structural analogue of platelet-activating factor to a neutral lipid in human leukemic K562 cells: relevance to the release of lipids. 2004 Biol. Pharm. Bull. pmid:14709893
Nakagawa K et al. Sperm-immobilizing antibodies suppress an increase in the plasma membrane fluidity of human spermatozoa. 2004 Fertil. Steril. pmid:15474073
Nie ZG et al. [Effects of ginkgolide B on lipopolysaccharide-induced TNFalpha production in mouse peritoneal macrophages and NF-kappaB activation in rat pleural polymorphonuclear leukocytes]. 2004 Yao Xue Xue Bao pmid:15491096
Barnes PJ Ceramide lances the lungs. 2004 Nat. Med. pmid:14760419
Goldring WP and Pattenden G Total synthesis of (+/-)-phomactin G, a platelet activating factor antagonist from the marine fungus Phoma sp. 2004 Org. Biomol. Chem. pmid:14770224
Rollin S et al. VEGF-mediated endothelial P-selectin translocation: role of VEGF receptors and endogenous PAF synthesis. 2004 Blood pmid:14764537
Chami O et al. Components of a platelet-activating factor-signaling loop are assembled in the ovine endometrium late in the estrous cycle. 2004 Am. J. Physiol. Endocrinol. Metab. pmid:15271646
Axelrad TW et al. Platelet-activating factor (PAF) induces activation of matrix metalloproteinase 2 activity and vascular endothelial cell invasion and migration. 2004 FASEB J. pmid:14715700
Chinybaeva LA [Comparative characterization of hemostatic parameters in patients with cerebral stroke]. 2004 Klin Med (Mosk) pmid:15449775
Gambero A et al. Signalling pathways regulating human neutrophil migration induced by secretory phospholipases A2. 2004 Toxicon pmid:15450921
Tokiwano T et al. Biosynthesis of phomactins: common intermediate phomactatriene and taxadiene. 2004 Chem. Commun. (Camb.) pmid:15154058
Zhelev DV et al. Controlled pseudopod extension of human neutrophils stimulated with different chemoattractants. 2004 Biophys. J. pmid:15240502
Hla T Prostaglandins & other lipid mediators: a new phase, a new team. 2004 Prostaglandins Other Lipid Mediat. pmid:15165026
Ruan Z et al. Effects of platelet-activating factor and thromboxane A2 on isolated perfused guinea pig liver. 2004 Prostaglandins Other Lipid Mediat. pmid:15165033
Nomikos TN et al. Application of a TCA-precipitation method for the determination of 1-alkyl-sn-glycero-3-phosphate: Acetyl-CoA acetyltransferase in human renal tissue. 2004 Prostaglandins Other Lipid Mediat. pmid:15165037
Kato M et al. Dual signaling and effector pathways mediate human eosinophil activation by platelet-activating factor. 2004 Int. Arch. Allergy Immunol. pmid:15166482
Besana A et al. Activation of protein kinase C epsilon inhibits the two-pore domain K+ channel, TASK-1, inducing repolarization abnormalities in cardiac ventricular myocytes. 2004 J. Biol. Chem. pmid:15184378
Michail S and Abernathy F A new model for studying eosinophil migration across cultured intestinal epithelial monolayers. 2004 J. Pediatr. Gastroenterol. Nutr. pmid:15187782
Lu H and Xue XD [Platelet-activating factor and neonatal necrotizing enterocolitis]. 2004 Zhonghua Er Ke Za Zhi pmid:15189692
Seyffarth G et al. Lipopolysaccharide induces nitric oxide synthase expression and platelet-activating factor increases nitric oxide production in human fetal membranes in culture. 2004 Reprod. Biol. Endocrinol. pmid:15191613
Lekka ME et al. The impact of intravenous fat emulsion administration in acute lung injury. 2004 Am. J. Respir. Crit. Care Med. pmid:14656749
Lu J et al. Platelet-activating factor-induced apoptosis is blocked by Bcl-2 in rat intestinal epithelial cells. 2004 Am. J. Physiol. Gastrointest. Liver Physiol. pmid:14512286
Buduneli E et al. Effects of combined systemic administration of low-dose doxycycline and alendronate on endotoxin-induced periodontitis in rats. 2004 J. Periodontol. pmid:15633329
Amer MD et al. Platelet-activating factor concentration in the stool of human newborns: effects of enteral feeding and neonatal necrotizing enterocolitis. 2004 Biol. Neonate pmid:14646336
Cinamon G et al. Chemoattractant signals and beta 2 integrin occupancy at apical endothelial contacts combine with shear stress signals to promote transendothelial neutrophil migration. 2004 J. Immunol. pmid:15585851
Bender A et al. Molecular surface point environments for virtual screening and the elucidation of binding patterns (MOLPRINT 3D). 2004 J. Med. Chem. pmid:15588092
Vardar S et al. Therapeutic versus prophylactic plus therapeutic administration of omega-3 fatty acid on endotoxin-induced periodontitis in rats. 2004 J. Periodontol. pmid:15732866
Wang Y et al. Opposing effect of angiopoietin-1 on VEGF-mediated disruption of endothelial cell-cell interactions requires activation of PKC beta. 2004 J. Cell. Physiol. pmid:14584044
Takeda K [Role of increase in permeability and circulatory failure in the development of organ dysfunction in severe acute pancreatitis]. 2004 Nippon Rinsho pmid:15552880
Takase K et al. [New aspects of pharmaco-therapy for acute pancreatitis]. 2004 Nippon Rinsho pmid:15552891
Ranasinghe S and Bolsover S Microglial calcium responses to platelet-activating factor are inhibited by analogue CAS 99103-16-9 and dihydropyridine PCA 4248 but not by ginkgolide A. 2004 Basic Clin. Pharmacol. Toxicol. pmid:15379786
Rothhut B Benveniste's reputation was not written in water. 2004 Nature pmid:15565124
Morita K et al. Development of tactile allodynia and thermal hyperalgesia by intrathecally administered platelet-activating factor in mice. 2004 Pain pmid:15363879
Serradji N et al. Structure-activity relationships in platelet-activating factor. 12. Synthesis and biological evaluation of platelet-activating factor antagonists with anti-HIV-1 activity. 2004 J. Med. Chem. pmid:15566310
Nemcsik J et al. Synergistic interaction of endogenous platelet-activating factor and vasopressin in generating angina in rats. 2004 Eur. J. Pharmacol. pmid:15363995
Roudebush WE et al. Exposure of preimplantation embryos to platelet-activating factor increases birth rate. 2004 J. Assist. Reprod. Genet. pmid:15568330
Zinchuk O et al. Dynamics of PAF-induced conjunctivitis reveals differential expression of PAF receptor by macrophages and eosinophils in the rat. 2004 Cell Tissue Res. pmid:15290234
Tarricone C et al. Coupling PAF signaling to dynein regulation: structure of LIS1 in complex with PAF-acetylhydrolase. 2004 Neuron pmid:15572112
Xu Y et al. Targeted disruption of PSD-93 gene reduces platelet-activating factor-induced neurotoxicity in cultured cortical neurons. 2004 Exp. Neurol. pmid:15296832
Wanten G et al. Lipid effects on neutrophil calcium signaling induced by opsonized particles: platelet activating factor is only part of the story. 2004 Clin Nutr pmid:15297099
Han XB et al. Macrophage inflammatory protein-2 mediates the bowel injury induced by platelet-activating factor. 2004 Am. J. Physiol. Gastrointest. Liver Physiol. pmid:15319184
Bossi F et al. Platelet-activating factor and kinin-dependent vascular leakage as a novel functional activity of the soluble terminal complement complex. 2004 J. Immunol. pmid:15557188
Kato M et al. Apafant, a potent platelet-activating factor antagonist, blocks eosinophil activation and is effective in the chronic phase of experimental allergic conjunctivitis in guinea pigs. 2004 J. Pharmacol. Sci. pmid:15286429
Fourcade O et al. Propofol inhibits human platelet aggregation induced by proinflammatory lipid mediators. 2004 Anesth. Analg. pmid:15271713
Rasheed H and Saeed SA Involvement of thromboxane A2 and tyrosine kinase in the synergistic interaction of platelet activating factor and calcium ionophore A23187 in human platelet aggregation. 2004 Exp. Mol. Med. pmid:15272233
Bate C et al. Phospholipase A2 inhibitors or platelet-activating factor antagonists prevent prion replication. 2004 J. Biol. Chem. pmid:15210691
Yamano S et al. Human spermatozoa capacitated with progesterone or a long incubation show accelerated internalization by an alkyl ether lysophospholipid. 2004 Fertil. Steril. pmid:15037409
Jakubowski A et al. Involvement of platelet activating factor in immediate heart response to lipopolysaccharide. 2004 J. Physiol. Pharmacol. pmid:15213362
Taylor KE Familial cancer and developmental dyslexia: an observational pilot study. 2004 Dev Med Child Neurol pmid:14974637
Seo KH et al. Essential role for platelet-activating factor-induced NF-kappaB activation in macrophage-derived angiogenesis. 2004 Eur. J. Immunol. pmid:15259010
Zhu P et al. Interplay among platelet-activating factor, oxidative stress, and group I metabotropic glutamate receptors modulates neuronal survival. 2004 J. Neurosci. Res. pmid:15264222
Lu DP et al. Trophic signals acting via phosphatidylinositol-3 kinase are required for normal pre-implantation mouse embryo development. 2004 J. Cell. Sci. pmid:15020683
Sarchielli P et al. Platelet-activating factor (PAF) in internal jugular venous blood of migraine without aura patients assessed during migraine attacks. 2004 Cephalalgia pmid:15265050
Ziche M Absence of PAF actions increases angiogenesis. 2004 Br. J. Pharmacol. pmid:15023858
Roudebush WE et al. Platelet-activating factor significantly enhances intrauterine insemination pregnancy rates in non-male factor infertility. 2004 Fertil. Steril. pmid:15236989
Ferreira MA et al. Sponge-induced angiogenesis and inflammation in PAF receptor-deficient mice (PAFR-KO). 2004 Br. J. Pharmacol. pmid:15023865
Alloatti G et al. Phosphoinositide 3-kinase gamma: kinase-dependent and -independent activities in cardiovascular function and disease. 2004 Biochem. Soc. Trans. pmid:15046613
Shio MT et al. PAF is involved in the Mycoplasma arthritidis superantigen-triggering pathway for iNOS and COX-2 expression in murine peritoneal cells. 2004 Exp. Cell Res. pmid:15242784
Naoki K et al. PAF responsiveness in Japanese subjects with plasma PAF acetylhydrolase deficiency. 2004 Biochem. Biophys. Res. Commun. pmid:15047169
Al-Darmaki S et al. Delineation of the role of platelet-activating factor in the immunoglobulin G2 antibody response. 2004 Clin. Diagn. Lab. Immunol. pmid:15242947
Sugatani J et al. Tea polyphenols inhibit acetyl-CoA:1-alkyl-sn-glycero-3-phosphocholine acetyltransferase (a key enzyme in platelet-activating factor biosynthesis) and platelet-activating factor-induced platelet aggregation. 2004 Int. Arch. Allergy Immunol. pmid:15051936
Tsironis LD et al. Effect of lipoprotein (a) on platelet activation induced by platelet-activating factor: role of apolipoprotein (a) and endogenous PAF-acetylhydrolase. 2004 Cardiovasc. Res. pmid:15194469
Aguiari G et al. Deficiency of polycystin-2 reduces Ca2+ channel activity and cell proliferation in ADPKD lymphoblastoid cells. 2004 FASEB J. pmid:15001556
Sumita C et al. Pioglitazone induces plasma platelet activating factor-acetylhydrolase and inhibits platelet activating factor-mediated cytoskeletal reorganization in macrophage. 2004 Biochim. Biophys. Acta pmid:15279882
Ma YQ et al. P-selectin binding to P-selectin glycoprotein ligand-1 induces an intermediate state of alphaMbeta2 activation and acts cooperatively with extracellular stimuli to support maximal adhesion of human neutrophils. 2004 Blood pmid:15217824
Du YM et al. Effects of platelet activating factor on action potentials and potassium channels in guinea-pig ventricular myocytes. 2004 Sheng Li Xue Bao pmid:15224138
Geromin D et al. Glycoprotein 170 induces platelet-activating factor receptor membrane expression and confers tumor cell hypersensitivity to NK-dependent cell lysis. 2004 J. Immunol. pmid:15004162
Pédrono F et al. Natural 1-O-alkylglycerols reduce platelet-activating factor-induced release of [3H]-serotonin in rabbit platelets. 2004 Prostaglandins Leukot. Essent. Fatty Acids pmid:15172680
Zimmerman GA and McIntyre TM PAF, ceramide and pulmonary edema: alveolar flooding and a flood of questions. 2004 Trends Mol Med pmid:15177186
Lee SH et al. Role of messenger RNA expression of platelet activating factor and its receptor in porcine in vitro-fertilized and cloned embryo development. 2004 Biol. Reprod. pmid:15151927
Ishii S et al. Platelet-activating factor receptor develops airway hyperresponsiveness independently of airway inflammation in a murine asthma model. 2004 J. Immunol. pmid:15153532
Zhang C et al. The effect of Ginkgo biloba extract (EGb 761) on hepatic sinusoidal endothelial cells and hepatic microcirculation in CCl4 rats. 2004 Am. J. Chin. Med. pmid:15154282
Saint-Martin F et al. A randomized, double-blind, parallel-group study, comparing the efficacy and safety of rupatadine (20 and 10 mg), a new PAF and H1 receptor-specific histamine antagonist, to loratadine 10 mg in the treatment of seasonal allergic rhinitis. 2004 J Investig Allergol Clin Immunol pmid:15160440
Xu Y and Tao YX Involvement of the NMDA receptor/nitric oxide signal pathway in platelet-activating factor-induced neurotoxicity. 2004 Neuroreport pmid:15076749
Slomiany BL and Slomiany A Platelet-activating factor mediates Porphyromonas gingivalis lipopolysaccharide interference with salivary mucin synthesis via phosphatidylinositol 3-kinase-dependent constitutive nitric-oxide synthase activation. 2004 J. Physiol. Pharmacol. pmid:15082869
Yang YM et al. Creation of reversed phase high-performance liquid chromatographic technique to assay platelet-activating factor. 2004 J. Zhejiang Univ. Sci. pmid:15101112
Ramos G et al. Platelet activating factor receptor binding plays a critical role in jet fuel-induced immune suppression. 2004 Toxicol. Appl. Pharmacol. pmid:15020195
Bate C et al. The role of platelet activating factor in prion and amyloid-beta neurotoxicity. 2004 Neuroreport pmid:15094513
Khreiss T et al. Activation of extracellular signal-regulated kinase couples platelet-activating factor-induced adhesion and delayed apoptosis of human neutrophils. 2004 Cell. Signal. pmid:15115659
Ninio E et al. Platelet-activating factor-acetylhydrolase and PAF-receptor gene haplotypes in relation to future cardiovascular event in patients with coronary artery disease. 2004 Hum. Mol. Genet. pmid:15115767
Bonin F et al. Anti-apoptotic actions of the platelet-activating factor acetylhydrolase I alpha2 catalytic subunit. 2004 J. Biol. Chem. pmid:15456758
Martin C et al. Pressor responses to platelet-activating factor and thromboxane are mediated by Rho-kinase. 2004 Am. J. Physiol. Lung Cell Mol. Physiol. pmid:15064228
Alfaro V Role of histamine and platelet-activating factor in allergic rhinitis. 2004 J. Physiol. Biochem. pmid:15457928
Baker KE and Curtis MJ Left regional cardiac perfusion in vitro with platelet-activating factor, norepinephrine and K+ reveals that ischaemic arrhythmias are caused by independent effects of endogenous "mediators" facilitated by interactions, and moderated by paradoxical antagonism. 2004 Br. J. Pharmacol. pmid:15066909
Uemura K et al. Superoxide production from human polymorphonuclear leukocytes by human mannan-binding protein (MBP). 2004 Glycoconj. J. pmid:15467404
Victorino GP et al. Modulation of microvascular hydraulic permeability by platelet-activating factor. 2004 J Trauma pmid:14960983
Ko HH et al. Structure-activity relationship studies on chalcone derivatives: potent inhibition of platelet aggregation. 2004 J. Pharm. Pharmacol. pmid:15482650
Ewer AK et al. The role of platelet activating factor in a neonatal piglet model of necrotising enterocolitis. 2004 Gut pmid:14724152
Angeli V et al. Dyslipidemia associated with atherosclerotic disease systemically alters dendritic cell mobilization. 2004 Immunity pmid:15485633
Tai H et al. TMVA, a snake C-type lectin-like protein from Trimeresurus mucrosquamatus venom, activates platelet via GPIb. 2004 Toxicon pmid:15501291